Magnetically-actuated drug delivery device (MADDD) for minimally invasive treatment of prostate cancer: An in vivo animal pilot study

The Prostate ◽  
2017 ◽  
Vol 77 (13) ◽  
pp. 1356-1365 ◽  
Author(s):  
Werner J. Struss ◽  
Zheng Tan ◽  
Payam Zachkani ◽  
Igor Moskalev ◽  
John K. Jackson ◽  
...  
RSC Advances ◽  
2015 ◽  
Vol 5 (119) ◽  
pp. 98087-98096 ◽  
Author(s):  
P. Zachkani ◽  
J. K. Jackson ◽  
F. N. Pirmoradi ◽  
M. Chiao

A cylindrical magnetically-actuated MEMS drug delivery device, implanted through a needle for localized prostate cancer treatment is proposed.


2019 ◽  
Vol 7 (6) ◽  
pp. 727-733
Author(s):  
Le Lin ◽  
Huai-Shan Hong ◽  
Yun-Liang Gao ◽  
Jin-Rui Yang ◽  
Tao Li ◽  
...  

2006 ◽  
Vol 116 (2) ◽  
pp. e47-e49 ◽  
Author(s):  
R.T. Pijls ◽  
H.H.L. Hanssen ◽  
R.M.M.A. Nuijts ◽  
G.W. Daube ◽  
L.H. Koole

2014 ◽  
Vol 13 (5) ◽  
pp. 705-708 ◽  
Author(s):  
Benedetto Neola ◽  
Stefano Capasso ◽  
Luca Caruso ◽  
Armando Falato ◽  
Giuseppe P Ferulano

Molecules ◽  
2021 ◽  
Vol 26 (19) ◽  
pp. 5912
Author(s):  
Jie Xu ◽  
Danfeng Xu ◽  
Xuan Xuan ◽  
Huacheng He

A microneedle (MN) is a painless and minimally invasive drug delivery device initially developed in 1976. As microneedle technology evolves, microneedles with different shapes (cone and pyramid) and forms (solid, drug-coated, hollow, dissolvable and hydrogel-based microneedles) have been developed. The main objective of this review is the applications of microneedles in biomedical areas. Firstly, the classifications and manufacturing of microneedle are briefly introduced so that we can learn the advantages and fabrications of different MNs. Secondly, research of microneedles in biomedical therapy such as drug delivery systems, diagnoses of disease, as well as wound repair and cancer therapy are overviewed. Finally, the safety and the vision of the future of MNs are discussed.


2010 ◽  
Vol 12 (1) ◽  
pp. 1-8 ◽  
Author(s):  
William Becker ◽  
Ildor Gabitov ◽  
Misha Stepanov ◽  
John Kois ◽  
Ami Smidt ◽  
...  

2018 ◽  
Vol 107 (6) ◽  
pp. 1605-1614 ◽  
Author(s):  
Angus R. Hibbins ◽  
Mershen Govender ◽  
Sunaina Indermun ◽  
Pradeep Kumar ◽  
Lisa C. du Toit ◽  
...  

2021 ◽  
Vol 7 (1) ◽  
pp. eabd4639
Author(s):  
Hyunwoo Joo ◽  
Youngsik Lee ◽  
Jaemin Kim ◽  
Jeong-Suk Yoo ◽  
Seungwon Yoo ◽  
...  

Personalized biomedical devices have enormous potential to solve clinical challenges in urgent medical situations. Despite this potential, a device for in situ treatment of fatal seizures using pharmaceutical methods has not been developed yet. Here, we present a novel treatment system for neurological medical emergencies, such as status epilepticus, a fatal epileptic condition that requires immediate treatment, using a soft implantable drug delivery device (SID). The SID is integrated wirelessly with wearable devices for monitoring electroencephalography signals and triggering subcutaneous drug release through wireless voltage induction. Because of the wireless integration, bulky rigid components such as sensors, batteries, and electronic circuits can be moved from the SID to wearables, and thus, the mechanical softness and miniaturization of the SID are achieved. The efficacy of the prompt treatment could be demonstrated with animal experiments in vivo, in which brain damages were reduced and survival rates were increased.


Sign in / Sign up

Export Citation Format

Share Document